NewsGermany
Scopien Technologies, an AI platform company based in Oakville, Ontario, has completed its acquisition of control of Cannabis Strategic Ventures, Inc. The closing was reported on 10 November 2026, with a new CEO and a name change at the Nevada-registered company.
Key points
- The stock purchase between Cannabis Strategic Ventures and Scopien Technologies has closed.
- Scopien holds voting control through Series B super-voting preferred shares; Zameer Mulla is the new CEO.
- An independent audit and an SEC registration filing are promised within six months.
CBD Hash at Spliff · from €3.50/g · ★ 4.9/5 (426 reviews)
72 h delivery in Europe · Free delivery from €99
The share purchase transaction between Cannabis Strategic Ventures and Scopien Technologies Inc. has closed, Markets Insider reported. Scopien now holds voting control of the company through its Series B super-voting preferred shares.
New management takes over
Zameer Mulla has been appointed president, CEO, treasurer, secretary and director. Richard C. Hawkins resigned from all of his officer and director roles.
All legacy Series C preferred shares have been cancelled. The company has also changed its name to Scopien Technologies Inc. with the Nevada Secretary of State.
Who is behind the deal
Cannabis Strategic Ventures is a Nevada company quoted on the OTC markets under the symbol NUGS. Its court-supervised restoration was completed in April 2026.
Scopien Technologies is a sovereign AI platform company based in Oakville, Ontario. It connects a business’s systems (CRM, ERP, HR, payroll and helpdesk) into a single platform.
Mulla said the move to a publicly traded company gives Scopien a platform to grow, increase sales and partnerships, and bring sovereign AI to more businesses and governments, according to the Markets Insider report.
Audit and SEC filing promised
The company has committed to a few steps after the change of control:
- an audit by an independent auditor registered with the PCAOB;
- a registration form filed with the SEC within six months;
- documentation submitted to FINRA for the name and symbol change.
It also plans to add independent directors, with a view to reaching SEC reporting status. A later application to list on a national stock exchange is possible but not confirmed.
Financial position and open questions
Total liabilities stood at $491,000 as of 30 September 2026, per the same report. Several points remain uncertain: FINRA approval of the new name and ticker, the timing of the audit and filing, market acceptance of the Scopien platform, and any extra financing.
What this changes for you
For a European shopper, there would be no direct consequence. The deal concerns a listed shell company and an AI software business, not products sold in Europe. The NUGS ticker may carry a cannabis-era name, but the change of control would not alter the rules for CBD or the range you can buy.
If you simply want to browse what is available, you can look at the CBD flower collection. Every Spliff product is lab-tested: THC content below 0.3% (0% for vapes and pods).
FAQ
What has Scopien Technologies acquired?
It has acquired voting control of Cannabis Strategic Ventures, Inc. through Series B super-voting preferred shares. The company has been renamed Scopien Technologies Inc. in Nevada.
Who runs the company now?
Zameer Mulla is president, CEO, treasurer, secretary and director. Richard C. Hawkins has resigned from all his roles.
What happens to the NUGS symbol?
The trading symbol is expected to change once FINRA approves it. That approval is not yet confirmed.
What comes next for the company?
It plans an independent PCAOB-registered audit and an SEC registration filing within six months, plus new independent directors.
Sources
- Markets Insider — Cannabis Strategic Ventures, Inc. Completes Change of Control with Scopien Technologies
- Investing.com Deutsch — Scopien Technologies übernimmt Kontrolle bei Cannabis Strategic Ventures
Image created with AI
